#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

Click here to read this study in NEJM.

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Positive lung cancer screens frequently receive suboptimal follow-up

Age-based screening for lung cancer may be more cost-effective and improve detection compared to current screening criteria in the United States

2 Minute Medicine Rewind November 24, 2025

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

Positive lung cancer screens frequently receive suboptimal follow-up

Age-based screening for lung cancer may be more cost-effective and improve detection compared to current screening criteria in the United States

2 Minute Medicine Rewind November 24, 2025

Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use

Minimally invasive surgery is beneficial for epithelial ovarian cancer

RelatedReports

Positive lung cancer screens frequently receive suboptimal follow-up

Age-based screening for lung cancer may be more cost-effective and improve detection compared to current screening criteria in the United States

2 Minute Medicine Rewind November 24, 2025

Ifinatam deruxtecan shows promising efficacy in extensive-stage small-cell lung cancer

Minimally invasive surgery is beneficial for epithelial ovarian cancer

Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation

Commonly cited medication triggers may not increase risk of microscopic colitis among older adults

Recent Reports